Reuters logo
BRIEF-Shionogi & Co Ltd signs strategic business alliance for sale of peripheral mu opioid receptor antagonist Symproic in U.S with Purdue Pharma L.P
December 19, 2016 / 6:15 AM / 10 months ago

BRIEF-Shionogi & Co Ltd signs strategic business alliance for sale of peripheral mu opioid receptor antagonist Symproic in U.S with Purdue Pharma L.P

Dec 19 (Reuters) - Shionogi & Co Ltd :

* Says it signed a strategic business alliance for sale of peripheral mu opioid receptor antagonist Symproic in U.S with Purdue Pharma L.P

Source text in Japanese: goo.gl/fPlM9G

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below